Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Margaret McLaughlin-Drubin, PH.D.

TitleInstructor in Medicine
InstitutionBrigham and Women's Hospital
DepartmentMedicine
AddressBrigham and Women's Hospital
Infectious Diseases
181 Longwood Ave
Boston MA 02115
Phone617/525-4241
Fax617/525-4251

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Munger K, Gwin TK, McLaughlin-Drubin ME. p16 in HPV-associated cancers. Oncotarget. 2013 Nov; 4(11):1864-5.
    View in: PubMed
  2. McLaughlin-Drubin ME, Park D, Munger K. Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines. Proc Natl Acad Sci U S A. 2013 Oct 1; 110(40):16175-80.
    View in: PubMed
  3. McLaughlin-Drubin ME, Munger K. Biochemical and functional interactions of human papillomavirus proteins with polycomb group proteins. Viruses. 2013; 5(5):1231-49.
    View in: PubMed
  4. Herfs M, Yamamoto Y, Laury A, Wang X, Nucci MR, McLaughlin-Drubin ME, Münger K, Feldman S, McKeon FD, Xian W, Crum CP. A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. Proc Natl Acad Sci U S A. 2012 Jun 26; 109(26):10516-21.
    View in: PubMed
  5. McLaughlin-Drubin ME, Meyers J, Munger K. Cancer associated human papillomaviruses. Curr Opin Virol. 2012 Aug; 2(4):459-66.
    View in: PubMed
  6. Levitt JM, McLaughlin-Drubin ME, Münger K, Georgakoudi I. Automated biochemical, morphological, and organizational assessment of precancerous changes from endogenous two-photon fluorescence images. PLoS One. 2011; 6(9):e24765.
    View in: PubMed
  7. McLaughlin-Drubin ME, Crum CP, Münger K. Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming. Proc Natl Acad Sci U S A. 2011 Feb 1; 108(5):2130-5.
    View in: PubMed
  8. McLaughlin-Drubin ME, Münger K. Oncogenic activities of human papillomaviruses. Virus Res. 2009 Aug; 143(2):195-208.
    View in: PubMed
  9. McLaughlin-Drubin ME, Münger K. The human papillomavirus E7 oncoprotein. Virology. 2009 Feb 20; 384(2):335-44.
    View in: PubMed
  10. Nguyen CL, McLaughlin-Drubin ME, Münger K. Delocalization of the microtubule motor Dynein from mitotic spindles by the human papillomavirus E7 oncoprotein is not sufficient for induction of multipolar mitoses. Cancer Res. 2008 Nov 1; 68(21):8715-22.
    View in: PubMed
  11. McLaughlin-Drubin M, Münger K. The human papillomavirus type 8 E2 gene encodes a transforming activity sufficient for skin tumor formation in transgenic mice. J Invest Dermatol. 2008 Sep; 128(9):2142-4.
    View in: PubMed
  12. McLaughlin-Drubin ME, Huh KW, Münger K. Human papillomavirus type 16 E7 oncoprotein associates with E2F6. J Virol. 2008 Sep; 82(17):8695-705.
    View in: PubMed
  13. Nguyen, CL McLaughlin-Drubin, ME Munger, K. Human Papillomaviruses and Associated Malignancies. Human Oncogenic Viruses. 2008.
  14. McLaughlin-Drubin ME, Munger K. Viruses associated with human cancer. Biochim Biophys Acta. 2008 Mar; 1782(3):127-50.
    View in: PubMed
  15. Levitt JM, Hunter M, Mujat C, McLaughlin-Drubin M, Münger K, Georgakoudi I. Diagnostic cellular organization features extracted from autofluorescence images. Opt Lett. 2007 Nov 15; 32(22):3305-7.
    View in: PubMed
  16. Drubin DA, McLaughlin-Drubin ME, Clawson GA, Meyers C. A protease inhibitor specifically inhibits growth of HPV-infected keratinocytes. Mol Ther. 2006 Jun; 13(6):1142-8.
    View in: PubMed
  17. McLaughlin-Drubin ME, Bromberg-White JL, Meyers C. The role of the human papillomavirus type 18 E7 oncoprotein during the complete viral life cycle. Virology. 2005 Jul 20; 338(1):61-8.
    View in: PubMed
  18. Sen E, McLaughlin-Drubin M, Meyers C. Efficacy of two commercial preparations of interferon-alpha on human papillomavirus replication. Anticancer Res. 2005 Mar-Apr; 25(2A):1091-100.
    View in: PubMed
  19. Alam S, Bromberg-White J, McLaughlin-Drubin M, Sen E, Bodily JM, Meyers C. Activity and therapeutic potential of ORI-1001 antisense oligonucleotide on human papillomavirus replication utilizing a model of dysplastic human epithelium. Anticancer Res. 2005 Mar-Apr; 25(2A):765-77.
    View in: PubMed
  20. McLaughlin-Drubin ME, Meyers C. Propagation of infectious, high-risk HPV in organotypic "raft" culture. Methods Mol Med. 2005; 119:171-86.
    View in: PubMed
  21. McLaughlin-Drubin ME, Christensen ND, Meyers C. Propagation, infection, and neutralization of authentic HPV16 virus. Virology. 2004 May 1; 322(2):213-9.
    View in: PubMed
  22. McLaughlin-Drubin ME, Meyers C. Evidence for the coexistence of two genital HPV types within the same host cell in vitro. Virology. 2004 Apr 10; 321(2):173-80.
    View in: PubMed
  23. McLaughlin-Drubin ME, Wilson S, Mullikin B, Suzich J, Meyers C. Human papillomavirus type 45 propagation, infection, and neutralization. Virology. 2003 Jul 20; 312(1):1-7.
    View in: PubMed
  24. McLaughlin-Drubin, ME. Development of Genetic Systems to Study the Differentiation-Dependent Life Cycle of Human Papillomaviruses. 2003.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
McLaughlin-Drubin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_